cytarabine and Cutaneous T-Cell Lymphoma

cytarabine has been researched along with Cutaneous T-Cell Lymphoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Leach, M; McKay, P; Oun, H; Wilson, M1
Chen, CC; Teng, CL; Yeh, SP1
Aragane, Y; Hashimoto, K; Isogai, R; Kanamaru, A; Kawada, A; Maeda, Y; Tezuka, T1
Bachelez, H; Brice, P; Dubertret, L; Dupuy, A; Janin, A; Lebbé, C; Mebazaa, A; Morel, P; Moulonguet, I; Mouly, F; Rivet, J; Rybojad, M; Vignon-Pennamen, MD1
Assanasen, T; Intragumtornchai, T; Nakorn, TN; Rojnuckarin, P; Wannakrairot, P1
Back, AL; Haycox, CL; Piepkorn, M; Raugi, GJ1
Alimena, G; Breccia, M; Carmosino, I; D'Andrea, M; D'Elia, GM; Petti, MC1
Atiq, OT; DeAngelis, LM; Portlock, CS; Rosenblum, M1

Reviews

1 review(s) available for cytarabine and Cutaneous T-Cell Lymphoma

ArticleYear
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review.
    Annals of hematology, 2016, Volume: 95, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclosporine; Cytarabine; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Multimodal Imaging; Panniculitis; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Skin Neoplasms; Subcutaneous Fat; Tomography, X-Ray Computed

2016

Other Studies

7 other study(ies) available for cytarabine and Cutaneous T-Cell Lymphoma

ArticleYear
Central nervous system relapse of primary cutaneous CD8
    British journal of haematology, 2021, Volume: 193, Issue:1

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autografts; CD8-Positive T-Lymphocytes; Central Nervous System; Cranial Nerve Diseases; Cytarabine; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Recurrence; Referral and Consultation; Remission Induction; Skin Neoplasms; Spinal Puncture; Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Treatment Outcome

2021
Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
    Dermatology (Basel, Switzerland), 2004, Volume: 209, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Facial Neoplasms; Humans; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Prednisone; Skin Neoplasms; Vincristine

2004
ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patients.
    The hematology journal : the official journal of the European Haematology Association, 2005, Volume: 5, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cisplatin; Cytarabine; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome

2005
Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Middle Aged; Panniculitis; Prednisone; Prognosis; Remission Induction; Skin Neoplasms; Treatment Outcome; Vincristine

2007
Subcutaneous T-cell lymphoma treated with systemic chemotherapy, autologous stem cell support, and limb amputation.
    Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:5 Pt 2

    Topics: Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leg; Lymphoma, T-Cell, Cutaneous; Male; Prednisone; Radiotherapy Dosage; Recombinant Proteins; Remission Induction; Vincristine; Whole-Body Irradiation

1997
Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: successful treatment with a fludarabine-containing regimen.
    European journal of haematology, 2002, Volume: 68, Issue:1

    Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Contraindications; Cytarabine; Disease Progression; Granulocyte Colony-Stimulating Factor; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Neoplasms, Second Primary; Remission Induction; Skin Neoplasms; Vidarabine

2002
Cutaneous T-cell lymphoma presenting with diffuse lymphomatous infiltration of the peripheral nerves: response to combination chemotherapy.
    American journal of clinical oncology, 1992, Volume: 15, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Etoposide; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Invasiveness; Peripheral Nervous System Neoplasms; Remission Induction; Skin Neoplasms

1992